Keyphrases
Acute Ischemic Stroke
100%
Cerebral Amyloid Angiopathy
41%
Intracerebral Hemorrhage
29%
Older Adults
25%
Tissue Plasminogen Activator (t-PA)
21%
Confidence Interval
20%
Recombinant Tissue Plasminogen Activator (rt-PA)
18%
White Matter Hyperintensities
17%
Discharge Outcomes
16%
Ischemic Stroke
16%
Alzheimer's Disease
15%
Diffusion-weighted Imaging
14%
Ambulance
14%
Small Vessel Disease
14%
Image Features
14%
Retrograde Amnesia
13%
Advanced Imaging
13%
Reperfusion
12%
Hemorrhagic Transformation
11%
Modified Rankin Scale
11%
Odds Ratio
10%
Endovascular Therapy
10%
Mechanical Thrombectomy
10%
Diffusion Magnetic Resonance Imaging (dMRI)
9%
Recanalization
9%
Stroke Outcome
9%
Reperfusion Therapy
8%
Neurological Improvement
8%
Thrombectomy
8%
Age Differences
8%
Clinical Trials
7%
Emergency Department
7%
Symptom Onset
7%
Hypertension
7%
Clinical Features
7%
National Institutes of Health Stroke Scale (NIHSS)
7%
Propensity Matching
7%
Periventricular
7%
United States
7%
Non-traumatic
7%
Magnetic Resonance Imaging
7%
Everolimus
6%
Distributed Databases
6%
Tissue-based
6%
Celecoxib
6%
Acute Ischemic
6%
Diagnostic Accuracy
6%
Hospital Characteristics
6%
Sentinel
6%
Silent Stroke
6%
Medicine and Dentistry
Apoplexy
91%
Brain Ischemia
77%
Alteplase
31%
Vascular Amyloidosis
30%
Cerebral Hemorrhage
26%
National Institutes of Health Stroke Scale
20%
Odds Ratio
19%
Magnetic Resonance Imaging
16%
Diffusion MRI
15%
Small Vessel Disease
15%
Systematic Review
15%
Prevalence
13%
Modified Rankin Scale
11%
Endovascular Surgery
11%
Recanalization
9%
Thrombectomy
8%
Triage
8%
Infarction
7%
Blood Clot Lysis
6%
Multivariate Analysis
6%
Everolimus
6%
Carotid Artery Stenosis
6%
Retina Ischemia
6%
Embolic Stroke
6%
ICD-9-CM
6%
Diagnosis Code
6%
Patient with Alzheimer's Disease
6%
Cranial Neuropathy
6%
Meta-Analysis
6%
Blood Pressure
6%
Carotid Artery Stenting
6%
Bilirubin
6%
Reperfusion Therapy
6%
Neurology
6%
Physiotherapy
6%
Cyclosporine
6%
Cerebral Venous Sinus Thrombosis
6%
Patient-Data
6%
Rapamycin
6%
Racial Disparity
6%
Left Ventricular Hypertrophy
6%
Nervous System Disorder
6%
Tacrolimus
6%
Stroke Therapy
6%
Tissue Plasminogen Activator
6%
Hazard Ratio
5%
Clinical Trial
5%
Infusion
5%
Flight
5%
Central Retinal Artery Occlusion
5%
